Kaya F, Van Duin C T, Van Miert A S
Department of Veterinary Basic Sciences, Faculty of Veterinary Medicine, Utrecht University, The Netherlands.
J Vet Pharmacol Ther. 1994 Apr;17(2):120-6. doi: 10.1111/j.1365-2885.1994.tb00221.x.
In ruminants, the dopaminergic regulation of feeding behaviour has not been investigated. Therefore, the effects of dopamine receptor agonists and antagonists on food intake and forestomach motility were studied in dwarf goats. Goats treated i.v. with bromocriptine (1 micrograms or 2.5 micrograms/kg body wt/min during 10 min) ate less food than when treated with saline. This inhibitory effect on food intake could not be prevented by the peripheral dopamine receptor antagonist domperidone (0.5 mg/kg body wt i.v.). In contrast, dopamine (i.v. 20 micrograms/kg body wt/min during 15 min), levodopa (i.v. 40 micrograms/kg body weight during 10 min), apomorphine (i.v. 2 micrograms/kg body wt/min during 10 min) and lisuride (i.v. 0.2 microgram/kg body wt/min during 15 min and 0.5 microgram/kg body wt during 10 min) failed to modify food intake. Given in association with benserazide, a decarboxylase inhibitor (i.v. 20 micrograms/kg body wt/min during 10 min), levodopa was still inactive as an anorectic agent. Levodopa, bromocriptine and lisuride administered at similar dose rates to those which were used in the food intake experiments, induced some clinical signs including inhibition of forestomach contractions. The inhibition of rumen contractions induced by these drugs was completely antagonized by domperidone pretreatment. These results, together with earlier in vivo and in vitro observations, suggest that the inhibitory effects of dopamine receptor agonists on forestomach contractions are due to interactions with peripheral dopaminergic receptors. The change in smooth muscle tension, which leads to a change in the signals transmitted via vagal afferents to the central nervous system, probably does not modify feeding behaviour in dwarf goats.(ABSTRACT TRUNCATED AT 250 WORDS)
在反刍动物中,尚未对进食行为的多巴胺能调节进行研究。因此,在矮山羊中研究了多巴胺受体激动剂和拮抗剂对食物摄入量和前胃运动的影响。静脉注射溴隐亭(1微克或2.5微克/千克体重/分钟,持续10分钟)的山羊比注射生理盐水的山羊进食量少。外周多巴胺受体拮抗剂多潘立酮(0.5毫克/千克体重,静脉注射)不能阻止这种对食物摄入的抑制作用。相比之下,多巴胺(静脉注射20微克/千克体重/分钟,持续15分钟)、左旋多巴(静脉注射40微克/千克体重,持续10分钟)、阿扑吗啡(静脉注射2微克/千克体重/分钟,持续10分钟)和利苏瑞ide(静脉注射0.2微克/千克体重/分钟,持续15分钟,然后0.5微克/千克体重,持续10分钟)未能改变食物摄入量。与脱羧酶抑制剂苄丝肼联合使用时(静脉注射20微克/千克体重/分钟,持续10分钟),左旋多巴作为一种食欲抑制剂仍然没有活性。以与食物摄入实验中相似的剂量率给药的左旋多巴、溴隐亭和利苏瑞ide会引发一些临床症状,包括抑制前胃收缩。多潘立酮预处理可完全拮抗这些药物诱导的瘤胃收缩抑制。这些结果,连同早期的体内和体外观察结果表明,多巴胺受体激动剂对前胃收缩的抑制作用是由于与外周多巴胺能受体的相互作用。平滑肌张力的变化,导致通过迷走神经传入中枢神经系统的信号发生变化,可能不会改变矮山羊的进食行为。(摘要截短为250字)